Lung Cancer

Real-World Data for Nivolumab in Patients with Malignant Mesothelioma
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Trastuzumab Deruxtecan in Patients with HER2-Mutated Advanced NSCLC
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Pralsetinib and Selpercatinib for NSCLC Patients with RET Gene Fusions
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Lorlatinib Improves Outcomes Over Crizotinib in First-Line Setting of ALK-Positive NSCLC
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Combination Ramucirumab and Erlotinib for NSCLC with EGFR Exon 19 or Exon 21 Mutations
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Capmatinib for Patients with NSCLC with MET Exon 14 Mutation
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Anti-TIGIT Antibody Tiragolumab plus Atezolizumab in Patients with PD-L1–Selected NSCLC
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Phase 3 EMPOWER-Lung 1 Study of Cemiplimab in Advanced PD-L1–Positive NSCLC
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Updated Analysis of PFS Data from Cohort G of KEYNOTE-021 in Nonsquamous NSCLC
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III NSCLC
2020 Year in Review - Lung Cancer - Lung Cancer
Read More
Page 4 of 11
Results 31 - 40 of 107